Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Jul 2016 07:00

RNS Number : 7982E
Quadrise Fuels International PLC
21 July 2016
 

21 July 2016

 

Quadrise Fuels International plc("Quadrise", "QFI'' or the "Company")

 

Directorate Change: Retirement of Non-Executive Director  

 

Quadrise Fuels International plc (AIM: QFI) is the emerging manufacturer and supplier of MSAR emulsion fuels, a low cost alternative to heavy fuel oil (one of the world's largest fuel markets comprising in excess of 450 million tons per annum) in the global shipping, refining and steam and power generation markets.

 

Quadrise announces that Dr. Ian Duckels, a Non-Executive Director of the Company, will be retiring as a director of Quadrise immediately after the 2016 AGM to be held during the last quarter of 2016. Dr. Duckels has been a director of the Company since September 2008 and will have served for over 8 years on his retirement. Prior to joining the board of QFI, Dr. Duckels had served as a director of Quadrise Limited from 1998 until its acquisition by QFI in 2006, following which he provided consultancy services to QFI.

 

QFI has an organised succession planning process in place and so will manage the transition smoothly, without needing to recruit an additional non-executive director at this stage. Philip Snaith, who was appointed as a Non-Executive Director in 2014, will succeed Dr Duckels as Chairman of the Remuneration Committee immediately after the 2016 AGM.

 

 

Mike Kirk, Executive Chairman of Quadrise said:

"Ian has made a significant contribution to the development of QFI and I have found his input hugely helpful during my transition from Non-Executive Director to Executive Chairman in April of this year. I look forward to continuing to work with Ian until the AGM and I and the board wish Ian all the best when he takes his well deserved retirement later this year."

 

 

Quadrise Fuels International plc

 

Mike Kirk, Executive Chairman

+44 (0)20 7031 7321

Hemant Thanawala, Finance Director

 

Jason Miles, Chief Operating Officer

 

 

Nominated Adviser

 

Smith & Williamson Corporate Finance Limited

 

Dr Azhic Basirov

+44 (0)20 7131 4000

Ben Jeynes

 

 

 

Broker

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

 

 

 

 

Public & Investor Relations

 

Bell Pottinger

 

Daniel Thöle

+44 (0)20 3772 2569

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPGUGGMUPQGMU
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.